K R Chaudhuri

Author PubWeight™ 57.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998 1.80
2 Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2013 1.61
3 Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 1999 1.59
4 Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996 1.58
5 What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology 1997 1.58
6 Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999 1.57
7 Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 1993 1.52
8 Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001 1.52
9 Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010 1.50
10 Restless legs syndrome. J Neurol Neurosurg Psychiatry 2001 1.44
11 Subcutaneous apomorphine in Parkinson's disease. BMJ 1998 1.41
12 Subcutaneous apomorphine for on-off oscillations in Parkinson's disease. Lancet 1988 1.35
13 What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997 1.35
14 International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009 1.34
15 Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996 1.32
16 Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 2006 1.27
17 Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 2000 1.17
18 Parkinson's disease in populations of African origin: a review. Neuroepidemiology 1996 1.15
19 Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 2008 1.09
20 Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord 2001 1.05
21 Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm (Vienna) 2001 1.03
22 Myasthenia gravis--a rare presentation with tongue atrophy and fasciculation. Age Ageing 2006 1.03
23 Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clin Auton Res 2001 1.00
24 Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology 1997 0.96
25 Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999 0.94
26 Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. Parkinsonism Relat Disord 1997 0.93
27 A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 2001 0.92
28 Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997 0.90
29 Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. J Neural Transm (Vienna) 2007 0.90
30 Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm (Vienna) 1998 0.90
31 Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999 0.89
32 The moving ear syndrome: a focal dyskinesia. J Neurol Neurosurg Psychiatry 1996 0.88
33 A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002 0.88
34 Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000 0.86
35 A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm. Neurology 2002 0.85
36 A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm (Vienna) 2001 0.84
37 Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry 1999 0.83
38 Repetitive belching, aerophagia, and torticollis in Huntington's disease: a case report. Mov Disord 1998 0.83
39 Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J Neurol Neurosurg Psychiatry 2001 0.83
40 Spontaneous dissections of the internal carotid artery: appearances on colour Doppler ultrasound. Br J Radiol 1997 0.83
41 Growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet 1992 0.81
42 Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy, and pure autonomic failure. Neurology 1993 0.81
43 No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun 1996 0.81
44 Limb contractures in levodopa-responsive parkinsonism: a clinical and investigational study of seven new cases. J Neurol 1999 0.80
45 MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine. Neuroreport 2001 0.79
46 Differential responses in superior mesenteric artery blood flow may explain the variant pressor responses to clonidine in two groups with sympathetic denervation. Clin Sci (Lond) 1992 0.78
47 Primary anticholinergic-responsive Pisa syndrome. Mov Disord 2000 0.78
48 Clinical risk-benefit assessment of dopamine agonists. Eur J Neurol 2008 0.78
49 Value of non-invasive continuous blood pressure monitoring in the detection of carotid sinus hypersensitivity. Clin Auton Res 1991 0.78
50 Study of EEGs following 24-hour sleep deprivation in patients with posttraumatic epilepsy. Eur Neurol 1992 0.77
51 Superior mesenteric artery vascular resistance is higher in hypertensives and is lowered by clonidine. J Hypertens Suppl 1991 0.77
52 Magnetic resonance spectroscopic study of parkinsonism related to boxing. J Neurol Neurosurg Psychiatry 1995 0.76
53 Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord 2001 0.76
54 Hemiplegia in pregnancy due to metastatic cerebral angiosarcoma. Eur Neurol 1994 0.76
55 Effects of oral alcohol on superior mesenteric artery blood flow in normal man, horizontal and tilted. Clin Sci (Lond) 1993 0.75
56 Genetic aspects of restless legs syndrome. Postgrad Med J 2006 0.75
57 How far are we in understanding the cause of Parkinson's disease? J Neurol Neurosurg Psychiatry 1997 0.75
58 Thermal thresholds and motor sensory conduction measurements in Guillain Barré syndrome: 12-month follow-up study. Eur Neurol 1992 0.75
59 Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electro-myography. J Neurol 2000 0.75
60 Human immunodeficiency virus-related progressive multifocal leukoencephalopathy presenting with an akinetic rigid syndrome. Mov Disord 1996 0.75
61 Treatment of Parkinson's disease and restless legs syndrome with cabergoline, a long-acting dopamine agonist. Int J Clin Pract 2002 0.75
62 Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine. Blood Press 1994 0.75
63 Effect of PGF 2 alpha and stress on the ascorbic acid content of rat adrenal gland (a histochemical observation). J Indian Med Assoc 1976 0.75
64 Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine. Eur J Neurol 1995 0.75